Objectives: It is uncertain whether dedicated neurocritical care units are associated with improved outcomes for critically ill neurologically injured patients in the era of collaborative protocol-driven care. We examined the association between dedicated neurocritical care units and mortality and the effects of standardized management protocols for severe traumatic brain injury. Design: We surveyed trauma medical directors from centers participating in the American College of Surgeons Trauma Quality Improvement Program to obtain information about ICU structure and processes of care. Survey data were then linked to the Trauma Quality Improvement Program registry, and random-intercept hierarchical multivariable modeling was used to evaluate the association between dedicated neurocritical care units, the presence of standardized management protocols and mortality. Setting: Trauma centers in North America participating in Trauma Quality Improvement Program. Patients: Data were analyzed from 9,773 adult patients with isolated severe traumatic brain injury admitted to 134 Trauma Quality Improvement Program centers between 2011 and 2013. Interventions: None. Measurements and Main Results: Only 50 ICUs (37%) were dedicated neurocritical care units, whereas 84 (63%) were general ICUs. Rates of standardized management protocols were similar comparing dedicated neurocritical care units and general ICUs. Among severe TBI patients admitted to trauma centers enrolled in Trauma Quality Improvement Program, care in a dedicated neurocritical care unit did not improve risk-adjusted in-hospital survival (odds ratio, 0.97; 95% CI, 0.80–1.19; p = 0.79). However, the presence of a standardized management protocol for these patients was associated with lower risk-adjusted in-hospital mortality (odds ratio, 0.77; 95% CI, 0.63–0.93; p = 0.009). Conclusions: Compared with dedicated neurocritical care models, standardized management protocols for severe traumatic brain injured patients are process-targeted intervention strategies that may improve clinical outcomes. The opinions, results, and conclusions reported in this article are those of the authors and are independent of funding sources. Dr. McCredie contributed to the literature search, study design, data analysis, data interpretation, writing, and critical revision. Drs. Alali, Scales, Rubenfeld, and Cuthbertson contributed to the study design, data interpretation, and critical revision. Dr. Nathens contributed to the study design, data analysis, data interpretation, and critical revision. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (https://ift.tt/29S62lw). Supported, in part, by a de Souza Chair in Trauma Research. Dr. Nathens received other support from a de Souza Chair in Trauma Research. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: Victoria.McCredie@uhn.ca Copyright © by 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
https://ift.tt/2uVXRxV
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
▼
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
-
▼
Απριλίου
(5349)
-
▼
Απρ 08
(30)
- Chemosensitizing Activity of Histone Deacetylases ...
- FOXP2 Promotes Tumor Proliferation and Metastasis ...
- DNA Fragmentation, Cell Cycle Arrest, and Docking ...
- Neoisoliquiritigenin Inhibits Tumor Progression by...
- Vaccine options for influenza: thinking small
- Ion channelopathies of the immune system
- Modulation of innate and adaptive immunity by P2X ...
- MET amplification, expression, and exon 14 mutatio...
- Lewy Body Disease: Clinical and Pathological “Over...
- Polysome Profiling in Leishmania, Human Cells and ...
- EMCrit RACC Podcast 222 / EDECMO Podcast – Demetri...
- A Fabrication and Measurement Method for a Flexibl...
- Re-Arterialized Rat Partial Liver Transplantation ...
- Presurgical pazopanib for renal cell carcinoma wit...
- Candidate Genes as Biomarkers in Lipopolysaccharid...
- Significant Changes in Plasma Alpha-Synuclein and ...
- Immunomodulatory Effects of Kuseonwangdogo-Based M...
- Genotypic Characterization of Rickettsia bellii Re...
- Mediolateral Differences of Proteoglycans Distribu...
- Impact of ICU Structure and Processes of Care on O...
- Early Enteral Nutrition Provided Within 24 Hours o...
- Ventilator Bundle and Its Effects on Mortality Amo...
- Inclusion of Unstructured Clinical Text Improves E...
- Markedly Deranged Injury Site Metabolism and Impai...
- Early Evidence of Sepsis-Associated Hyperperfusion...
- End-of-Life Care in ICUs in East Asia: A Compariso...
- An Open-Loop, Physiologic Model–Based Decision Sup...
- Clinical Outcomes and Mortality Impact of Hyperbar...
- Septate Uterus in a Girl with Rubinstein–Taybi Syn...
- Evaluation of Cytochalasin B-Induced Membrane Vesi...
-
▼
Απρ 08
(30)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
https://ift.tt/2MQ8Ai8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.